L-DOPA methyl ester (hydrochloride)

CAS No. 1421-65-4

L-DOPA methyl ester (hydrochloride)( —— )

Catalog No. M20919 CAS No. 1421-65-4

L-DOPA methyl ester (LDME) is an agonist of dopamine D1 receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG 41 In Stock
200MG Get Quote In Stock
500MG 114 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    L-DOPA methyl ester (hydrochloride)
  • Note
    Research use only, not for human use.
  • Brief Description
    L-DOPA methyl ester (LDME) is an agonist of dopamine D1 receptor.
  • Description
    L-DOPA methyl ester (LDME) is an agonist of dopamine D1 receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    D1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1421-65-4
  • Formula Weight
    247.7
  • Molecular Formula
    C10H14ClNO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC(=O)[C@@H](N)Cc1ccc(O)c(O)c1.Cl
  • Chemical Name
    Alanine 3-(34-dihydroxyphenyl)- methyl ester hydrochloride l-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Li R Liang T Chen Z et al. l-Dopa methyl ester attenuates amblyopia-induced neuronal injury in visual cortex of amblyopic cat[J]. Gene 2013 527(1):115-122.
molnova catalog
related products
  • PNU-177864 hydrochlo...

    PNU-177864 hydrochloride is a selective antagonist of D3 receptor with antischizophrenic activity.

  • Quinpirole Hydrochlo...

    Quinpirole Hydrochloride (LY 171555), as an agonist with high affinity for dopamine receptor D2/D3, has been widely used to study the function of dopamine receptor D2/D3 in humans and mice

  • Fluphenazine decanoa...

    Fluphenazine decanoate is dopamine D2 receptor blockeand is a long-acting phenothiazine neuroleptic that used to treat schizophrenia.